Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Endocrinological Investigation|February 1, 1983
Reenlargement of macroprolactinomas during bromocriptine treatment: report of two casesD Dallabonzana, B Spelta, G Oppizzi, et al.The New England Journal of Medicine|September 12, 1985
Low doses of dopamine agonists in the long-term treatment of macroprolactinomasA Liuzzi, D Dallabonzana, G Oppizzi, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1984
Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor sizeG Oppizzi, A Liuzzi, P Chiodini, et al.The Journal of Clinical Endocrinology and Metabolism|December 1, 1986
Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluationG Oppizzi, M M Petroncini, D Dallabonzana, et al.European Journal of Endocrinology|February 26, 1999
Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalicsR Attanasio, G Oppizzi, S Lodrini, et al.Journal of Endocrinological Investigation|November 19, 1997
Effects of tamoxifen on GH and IGF-I levels in acromegalyR Cozzi, R Attanasio, G Oppizzi, et al.Journal of Endocrinological Investigation|May 9, 2000
From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's diseaseM Barausse, R Attanasio, D Dallabonzana, et al.European Journal of Clinical Investigation|April 1, 1997
Clinical results of long-term slow-release lanreotide treatment of acromegalyM Giusti, E Ciccarelli, D Dallabonzana, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1987
Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptineP G Chiodini, R Cozzi, D Dallabonzana, et al.Pageof 3